Xenon Pharmaceuticals Company Profile (NASDAQ:XENE)

About Xenon Pharmaceuticals

Xenon Pharmaceuticals Inc. (Xenon) is a biopharmaceutical company discovering and developing a pipeline of differentiated therapeutics for orphan indications. The Company's platform, Extreme Genetics, enables the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels (channelopathies). Extreme Genetics involves the study of families where individuals exhibit inherited severe traits, or phenotypes. Its integrated platform includes in-house capabilities for human genetics, small molecule drug discovery, as well as preclinical and clinical development. Its pharmaceutical partners include Teva Pharmaceutical Industries, Ltd. (Teva), Genentech, Inc. (Genentech) and Merck & Co., Inc. (Merck). Extreme Genetics discovery platform has yielded the first approved gene therapy product in the European Union, or the EU, and a development pipeline, including Glybera, TV-45070, GDC-0276 and GDC-0310, and XEN801.

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: XENE
CUSIP:

Key Metrics:

Previous Close: $8.15
50 Day Moving Average: $7.97
200 Day Moving Average: $7.25
52-Week Range: $5.65 - $10.07
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -14.45
P/E Growth: -0.52
Market Cap: $120.17M
Outstanding Shares: 14,426,000
Beta: 1.43

Profitability:

Net Margins: -199.68%
Return on Equity: -28.85%
Return on Assets: -27.19%

Debt:

Current Ratio: 18.28%
Quick Ratio: 18.28%

Additional Links:

Companies Related to Xenon Pharmaceuticals:

Consensus Ratings for Xenon Pharmaceuticals (NASDAQ:XENE) (?)

Ratings Breakdown:	3 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$16.33 (105.45% upside)

Analysts' Ratings History for Xenon Pharmaceuticals (NASDAQ:XENE)

Show:

Date	Firm	Action	Rating	Price Target
9/26/2016	Guggenheim	Initiated Coverage	Buy -> Buy	$20.00
8/5/2016	Canaccord Genuity	Reiterated Rating	Buy	$16.00
5/11/2016	Jefferies Group	Reiterated Rating	Buy	$13.00
9/24/2015	SEB Equity Research	Reiterated Rating	Positive
12/1/2014	Wells Fargo & Co.	Initiated Coverage	Outperform

(Data available from 9/29/2014 forward)

Earnings History for Xenon Pharmaceuticals (NASDAQ:XENE)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/8/2016
8/3/2016	Q216	($0.48)	($0.42)	$2.25 million		View	N/A
5/10/2016	Q116	($0.21)	($0.23)	$3.30 million		View	Listen
3/8/2016	Q415	($0.16)	($0.27)	$4.65 million		View	Listen
11/10/2015	Q315	($0.02)	($0.27)	$4.65 million	$4.29 million	View	Listen
8/10/2015	Q215	($0.16)	($0.07)	$4.23 million		View	Listen
5/12/2015	Q115	$0.14	($0.30)	$4.65 million	$4.00 million	View	Listen
3/12/2015	Q4	($0.09)	$1.57			View	Listen
12/16/2014		$0.41	$1.69			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Xenon Pharmaceuticals (NASDAQ:XENE)

Current Year EPS Consensus Estimate: $-1.55 EPS
Next Year EPS Consensus Estimate: $-0.55 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.21)	($0.21)	($0.21)
Q2 2016	1	($0.24)	($0.24)	($0.24)
Q3 2016	1	($0.47)	($0.47)	($0.47)
Q4 2016	1	($0.48)	($0.48)	($0.48)

(Data provided by Zacks Investment Research)

Dividend History for Xenon Pharmaceuticals (NASDAQ:XENE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Xenon Pharmaceuticals (NASDAQ:XENE)

Insider Ownership Percentage: 11.10%
Institutional Ownership Percentage: 30.89%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/19/2016	Frank A Holler	Director	Sell	11,938	$7.65	$91,325.70
8/18/2016	Frank A Holler	Director	Sell	18,062	$7.93	$143,231.66
6/24/2016	Ian Mortimer	CFO	Buy	5,300	$6.22	$32,966.00
9/24/2015	Y. Paul Goldberg	VP	Sell	22,149	$8.88	$196,683.12

(Data available from 1/1/2013 forward)

Latest Headlines for Xenon Pharmaceuticals (NASDAQ:XENE)

Date	Headline
	Coverage initiated on Xenon Pharmaceuticals by Guggenheim (NASDAQ:XENE) finance.yahoo.com - September 26 at 8:08 PM
	Xenon Pharmaceuticals Announces Closing of $34.5 Million Public Offering (NASDAQ:XENE) www.bctechnology.com - September 21 at 12:02 PM
	Xenon pharmaceuticals reports second quarter 2016 financial results and provides corporate update nasdaq_xene data recovery nj (NASDAQ:XENE) handyrecovery.in - September 19 at 3:15 PM
	Xenon Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:XENE) www.4-traders.com - September 17 at 7:32 PM
	Xenon Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Closing of $34.5 Million Public Offering (NASDAQ:XENE) www.publicnow.com - September 14 at 12:34 PM
	Xenon Pharmaceuticals Inc. (XENE): Biotechnology Value Fund Adds More Shares (NASDAQ:XENE) feedproxy.google.com - September 12 at 1:24 PM
	XENON PHARMACEUTICALS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:XENE) biz.yahoo.com - September 9 at 7:47 PM
	Xenon Pharmaceuticals (XENE) Prices $30M Common Stock Offering (NASDAQ:XENE) www.streetinsider.com - September 8 at 12:07 PM
	Xenon Pharmaceuticals Announces Pricing of $30 Million Public Offering of Common Shares (NASDAQ:XENE) www.publicnow.com - September 8 at 12:07 PM
	4:33 pm Xenon Pharmaceuticals announces proposed public offering of common shares by existing security holders (NASDAQ:XENE) finance.yahoo.com - September 7 at 8:16 PM
	Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares (NASDAQ:XENE) www.publicnow.com - September 7 at 8:16 PM
	Xenon Pharmaceuticals, Inc. :XENE-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (NASDAQ:XENE) www.capitalcube.com - August 11 at 11:50 AM
	Edited Transcript of XENE earnings conference call or presentation 3-Aug-16 8:30pm GMT (NASDAQ:XENE) finance.yahoo.com - August 8 at 8:34 PM
	Xenon Expects XEN801 Results In Q1 2017, Delayed One Quarter (NASDAQ:XENE) www.benzinga.com - August 5 at 11:27 AM
	Xenon Pharmaceuticals Inc.: Xenon Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:XENE) www.twst.com - August 5 at 11:27 AM
	Xenon Pharmaceuticals reports 2Q loss (NASDAQ:XENE) sg.finance.yahoo.com - August 3 at 8:45 PM
	Q2 2016 Xenon Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:XENE) biz.yahoo.com - August 3 at 11:42 AM
	Xenon Pharmaceuticals to Present at the Canaccord Genuity 36th Annual Growth Conference (NASDAQ:XENE) finance.yahoo.com - August 2 at 8:46 PM
	Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2016 Financial Results and Provide Corporate Update (NASDAQ:XENE) www.publicnow.com - July 25 at 4:48 PM
	Xenon Pharmaceuticals Presents Corporate Update and Highlights Its Proprietary Therapeutic Programs at the Jefferies 2016 Healthcare Conference (NASDAQ:XENE) www.publicnow.com - June 8 at 7:58 AM
	XENON PHARMACEUTICALS INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:XENE) biz.yahoo.com - June 3 at 4:32 PM
	Xenon Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference (NASDAQ:XENE) www.publicnow.com - June 2 at 8:25 AM
	Xenon Pharmaceuticals, Inc. :XENE-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:XENE) www.capitalcube.com - May 17 at 4:34 PM
	Xenon Pharmaceuticals reports 1Q loss (NASDAQ:XENE) sg.finance.yahoo.com - May 10 at 5:28 PM
	Xenon Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today (NASDAQ:XENE) biz.yahoo.com - May 10 at 4:30 PM
	Xenon Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:XENE) www.publicnow.com - May 10 at 4:18 PM
	Q1 2016 Xenon Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:XENE) biz.yahoo.com - May 10 at 7:07 AM
	Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2016 Financial Results and Provide Corporate Update (NASDAQ:XENE) www.publicnow.com - May 2 at 4:30 PM
	Edited Transcript of XENE earnings conference call or presentation 8-Mar-16 9:30pm GMT (NASDAQ:XENE) finance.yahoo.com - April 7 at 11:41 AM
	Xenon Names Dr. Raymond J. Winquist as Head, Translational Research (NASDAQ:XENE) www.publicnow.com - April 4 at 5:00 PM
	Xenon Pharma Will Offer Business, Milestone Update at Needham Conference (NASDAQ:XENE) feeds.benzinga.com - March 31 at 5:22 PM
	Xenon Pharmaceuticals to Provide Business and Milestone Update at Needham Healthcare Conference (NASDAQ:XENE) www.publicnow.com - March 31 at 4:55 PM
	Xenon Pharmaceuticals To Host Conference Call And Webcast To Discuss 2015 Financial Results And Provide Corporate Update (NASDAQ:XENE) www.thestreet.com - March 1 at 9:25 PM
	Xenon Pharmaceuticals Inc. (XENE) Broker Views - Risers & Fallers (NASDAQ:XENE) www.risersandfallers.com - February 26 at 1:48 PM
	Xenon Pharmaceuticals, Inc.: Price momentum supported by strong fundamentals (NASDAQ:XENE) www.capitalcube.com - February 18 at 4:24 PM
	Xenon Initiates Phase 2 Clinical Trial of XEN801 to Treat Moderate to Severe Acne (NASDAQ:XENE) finance.yahoo.com - February 10 at 8:00 AM
	Xenon Names Dr. James R. Empfield Senior Vice President, Drug Discovery (NASDAQ:XENE) finance.yahoo.com - February 9 at 8:00 AM
	Price Target Update On Xenon Pharmaceuticals Inc. (XENE) - Risers & Fallers (NASDAQ:XENE) www.risersandfallers.com - February 2 at 2:45 PM
	Xenon Pharmaceuticals Inc. (XENE) Recent Analyst Updates - Risers & Fallers (NASDAQ:XENE) www.risersandfallers.com - January 21 at 1:34 PM
	Xenon Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers (NASDAQ:XENE) www.capitalcube.com - December 23 at 1:08 PM
	Xenon and Genentech Publish in Science the 3-D Crystal Structure of a Novel Nav1.7 Compound Binding Site Enabling the Development of Potent Selective Inhibitors to Treat Pain (NASDAQ:XENE) www.noodls.com - December 17 at 2:43 PM
	XENON PHARMACEUTICALS INC. Financials (NASDAQ:XENE) finance.yahoo.com - December 8 at 1:17 PM
	Should You Buy Energy Focus Inc (EFOI)? (NASDAQ:XENE) www.insidermonkey.com - December 8 at 10:59 AM
	Xenon Pharmaceuticals to Present at the Stifel 2015 Healthcare Conference (NASDAQ:XENE) www.noodls.com - November 12 at 4:46 PM
	Xenon Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today (NASDAQ:XENE) biz.yahoo.com - November 10 at 5:00 PM
	Xenon Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Corporate Update (NASDAQ:XENE) www.noodls.com - November 10 at 4:56 PM
	Xenon Pharmaceuticals reports 3Q loss (NASDAQ:XENE) sg.finance.yahoo.com - November 10 at 4:47 PM
	XENON PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an (NASDAQ:XENE) biz.yahoo.com - November 10 at 4:32 PM